Neoral oral solution (DrugBank: -)
1 disease| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 269 | Pyogenic arthritis | 1 |
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | EUCTR2008-008291-14-IE (EUCTR) | 31/03/2010 | 08/10/2009 | Study of treatments in Pyoderma Gangrenosum patients - STOP GAP | Study of treatments in Pyoderma Gangrenosum patients - STOP GAP | pyoderma gangrenosum MedDRA version: 9.1;Level: LLT;Classification code 10037634;Term: Pyoderma gangenosum MedDRA version: 9.1;Classification code 10037635;Term: Pyoderma gangrenosum | Trade Name: Neoral soft gelatin capsules INN or Proposed INN: CICLOSPORIN Trade Name: Neoral Oral Solution INN or Proposed INN: CICLOSPORIN Product Name: Prednisolone INN or Proposed INN: PREDNISOLONE Product Name: Prednisolone INN or Proposed INN: PREDNISOLONE Product Name: Prednisolone INN or Proposed INN: PREDNISOLONE | Nottingham University Hospitals NHS Trust | NULL | Not Recruiting | Female: yes Male: yes | Ireland;United Kingdom |